Concepedia

K. A. Dicke

KA

Statistics

Publications

12

Citations

1.2K

H-Index

12

Active since

1979

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Palmetto Hematology Oncology

The University of Texas Health Science Center at Houston

University of Nebraska Medical Center

K. A. Dicke is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, chemotherapy, and hematology.

Publications per year

1979–1996

12

Publications

12

High-dose melphalan with autologous bone marrow transplantation for multiple myeloma

Barthel Barlogie, R Hall, A Zander et al. · Blood · 1986 · 327 citations · Full text

Medicine, Hematology, Oncology +16

Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease.

Sundar Jagannath, Jamés O. Armitage, K. A. Dicke et al. · Journal of Clinical Oncology · 1989 · 210 citations

Medicine, Oncology, Radiation Oncology +14

Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia.

Hagop M. Kantarjian, R S Walters, Michael J. Keating et al. · Journal of Clinical Oncology · 1990 · 170 citations

Medicine, Oncology, Pharmacology +17

High dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: Long term follow-up in 128 patients

Philip J. Bierman, Robert Bagin, Sundar Jagannath et al. · Annals of Oncology · 1993 · 161 citations · Full text

Medicine, Hematology, Oncology +14

Chemotherapy versus transplants for acute myelogenous leukemia in second remission.

R P Gale, Mary M. Horowitz, J. K. H. Rees et al. · PubMed · 1996 · 79 citations

Medicine, Hematology, Oncology +13

1–5 of 12